Valuation: Getinge AB

Market Cap 67.03B 7.07B 6.06B 5.65B 5.18B 9.74B 677B 9.93B 26.13B 339B 26.56B 25.98B 1,123B P/E 2026 *
21.7x
P/E 2027 * 19.3x
Enterprise Value 75.59B 7.98B 6.83B 6.37B 5.85B 10.99B 763B 11.2B 29.47B 382B 29.95B 29.3B 1,266B EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.98x
Free-Float
78.61%
Yield 2026 *
2.11%
Yield 2027 * 2.29%
1 day-0.04%
1 week+2.56%
Current month+3.74%
1 month+7.99%
3 months+22.22%
6 months+15.05%
Current year+9.09%
1 week 25.11
Extreme 25.11
25.93
1 month 23.42
Extreme 23.415
25.93
Current year 18.99
Extreme 18.99
25.93
1 year 18.99
Extreme 18.99
25.93
3 years 14.84
Extreme 14.84
25.93
5 years 14.84
Extreme 14.84
48.89
10 years 8.31
Extreme 8.31
48.89
Manager TitleAgeSince
Chief Executive Officer 54 30/04/2017
Director of Finance/CFO 48 30/03/2024
Compliance Officer 47 30/09/2020
Director TitleAgeSince
Chairman 65 22/04/2019
Chairman 75 -
Director/Board Member 70 31/12/2006
Change 5-day change 1-year change 3-year change Capi.($)
-0.04%+2.56% - - 7.03B
-0.94%-0.92%+26.61%+30.18% 12.87B
+0.82%+2.84%+19.35%+34.70% 7.03B
+3.83%+5.37%+54.40%+50.48% 6.65B
-0.20%+0.80% - - 5.68B
+16.51%+23.25%-7.18%+88.91% 4.73B
+1.51%-2.67%-27.01%-22.00% 3.84B
-2.36%+2.24%+50.85%-42.95% 2.12B
+0.16%-6.50%+46.61%-8.84% 1.62B
+1.31%+2.65%-33.17%+124.90% 1.6B
Average +2.06%+2.34%+16.31%+31.92% 5.13B
Weighted average by Cap. +1.86%+2.45%+20.58%+34.57%

Financials

2026 *2027 *
Net sales 35.16B 3.71B 3.18B 2.96B 2.72B 5.11B 355B 5.21B 13.71B 178B 13.93B 13.63B 589B 37.08B 3.91B 3.35B 3.13B 2.87B 5.39B 374B 5.5B 14.46B 188B 14.69B 14.37B 621B
Net income 3.09B 326M 279M 260M 239M 449M 31.16B 457M 1.2B 15.62B 1.22B 1.2B 51.7B 3.46B 365M 312M 291M 267M 502M 34.91B 512M 1.35B 17.49B 1.37B 1.34B 57.91B
Net Debt 8.56B 903M 773M 722M 662M 1.24B 86.43B 1.27B 3.34B 43.32B 3.39B 3.32B 143B 6.33B 668M 572M 533M 489M 920M 63.89B 938M 2.47B 32.02B 2.51B 2.45B 106B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Date Price Change Volume
20/08/26 US$25.80 -0.04% 2,346
19/08/26 US$25.81 +2.54% 2,130
18/08/26 US$25.17 +0.16% 8,605
17/08/26 US$25.13 -0.10% 2,274
14/08/26 US$25.16 +0.71% 390
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
244.10SEK
Average target price
237.90SEK
Spread / Average Target
-2.54%

Quarterly revenue - Rate of surprise